Literature DB >> 11288748

Microsatellite instability as a molecular marker for very good survival in colorectal cancer patients receiving adjuvant chemotherapy.

H Elsaleh, B Shannon, B Iacopetta.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11288748     DOI： 10.1053/gast.2001.23646

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  12 in total

1.  The changing face of familial colorectal cancer.

Authors:  Ayan Banerjea; Sue Clark; Sina Dorudi
Journal:  BMJ       Date:  2005-01-01

2.  Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications.

Authors:  Aziz Zaanan; Katy Meunier; Fatiha Sangar; Jean-François Fléjou; Françoise Praz
Journal:  Cell Oncol (Dordr)       Date:  2011-04-12       Impact factor: 6.730

Review 3.  Biomarker in Colorectal Cancer.

Authors:  Marta Schirripa; Heinz-Josef Lenz
Journal:  Cancer J       Date:  2016 May-Jun       Impact factor: 3.360

4.  Pathologic predictors of microsatellite instability in colorectal cancer.

Authors:  Joel K Greenson; Shu-Chen Huang; Casey Herron; Victor Moreno; Joseph D Bonner; Lynn P Tomsho; Ofer Ben-Izhak; Hector I Cohen; Phillip Trougouboff; Jacob Bejhar; Yanina Sova; Mila Pinchev; Gad Rennert; Stephen B Gruber
Journal:  Am J Surg Pathol       Date:  2009-01       Impact factor: 6.394

5.  5-fluorouracil (5FU) treatment does not influence invasion and metastasis in microsatellite unstable (MSI-H) colorectal cancer.

Authors:  Janindra Warusavitarne; Palaniappan Ramanathan; Anthony Kaufman; Bruce G Robinson; Margaret Schnitzler
Journal:  Int J Colorectal Dis       Date:  2006-03-24       Impact factor: 2.571

6.  Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer.

Authors:  U Wallin; B Glimelius; K Jirström; S Darmanis; R Y Nong; F Pontén; C Johansson; L Påhlman; H Birgisson
Journal:  Br J Cancer       Date:  2011-04-05       Impact factor: 7.640

Review 7.  Deficient mismatch repair: Read all about it (Review).

Authors:  Susan Richman
Journal:  Int J Oncol       Date:  2015-08-12       Impact factor: 5.650

8.  Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy.

Authors:  Ioannis Kostopoulos; Vasilios Karavasilis; Maria Karina; Mattheos Bobos; Nikolaos Xiros; George Pentheroudakis; Georgia Kafiri; Pavlos Papakostas; Eleni Vrettou; George Fountzilas
Journal:  BMC Cancer       Date:  2009-09-24       Impact factor: 4.430

9.  Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer.

Authors:  M Mrkonjic; E Chappell; V V Pethe; M Manno; D Daftary; C M Greenwood; S Gallinger; B W Zanke; J A Knight; B Bapat
Journal:  Br J Cancer       Date:  2009-05-19       Impact factor: 7.640

10.  The expression of mismatched repair genes and their correlation with clinicopathological parameters and response to neo-adjuvant chemotherapy in breast cancer.

Authors:  Binita P Jha; Vimal Bhandari; Anju Bansal; Sunita Saxena; Dinesh Bhatnagar
Journal:  Int Semin Surg Oncol       Date:  2007-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.